ABT vs GTM · P/E 25, rev $44.33B vs P/E 6.9, rev $620.6M
Abbott Laboratories (ABT) versus ZoomInfo Technologies Inc. (GTM) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
ZoomInfo Technologies Inc. (GTM) is a software - application company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported GTM revenue for 2026-06-30 was $620.6M. Net income was -$614.4M. GTM currently screens at market cap $816.4M and trailing P/E 6.9.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. GTM currently screens at market cap $816.4M and trailing P/E 6.9.
Not investment advice. Open the ABT and GTM stock pages for the full models.
Not investment advice.